Bilirubin inhibits Ca2+-dependent release of norepinephrine from permeabilized nerve terminals.
Although the well-known neurotoxic agent bilirubin can induce alterations in neuronal signaling, direct effects on neurotransmitter release have been difficult to demonstrate. In the present study we have used permeabilized nerve terminals (synaptosomes) from rat brain prelabeled with [3H]norepinephrine to examine the effects of bilirubin on transmitter release. Rat cerebrocortical synaptosomes were permeabilized with streptolysin-O (2 U/ml) in the absence or presence of bilirubin (10 microM-320 microM) and Ca2+ (100 microM), and the amount of radiolabeled transmitter released during 5 min to the medium was analysed. Low levels of bilirubin decreased Ca2+-evoked release in a dose-dependent manner, with half-maximal effect at approx 25 microM bilirubin. Higher levels of bilirubin (100-320 microM) increased [3H]norepinephrine efflux in the absence of Ca2+, suggesting that high bilirubin levels induced leakage of transmitter from vesicles. The nontoxic precursor biliverdin had no effect on Ca2+-dependent exocytosis. Our data indicate that bilirubin directly inhibits both exocytotic release and vesicular storage of brain catecholamines.
Hansen
T W
TW
Department Group of Basic Medical Sciences, University of Oslo, Norway.
Mathiesen
S B
SB
Sefland
I
I
Walaas
S I
SI
D000818:Animals; D001663:Bilirubin / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism*; D005089:Exocytosis / Q000187:drug effects; D005260:Female; D008297:Male; D009411:Nerve Endings / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010539:Permeability; D051381:Rats; D017208:Rats, Wistar; D014316:Tritium
D014316:Tritium; D001663:Bilirubin; D002118:Calcium; D009638:Norepinephrine